Aurobindo Pharma reports over 9% rise in Q1 consolidated net profit

14 Aug 2023 Evaluate

Aurobindo Pharma has reported results for first quarter ended June 30, 2023 (Q1FY24). 

The company has reported over 2-fold jump in its net profit at Rs 335.95 crore for the quarter under review as compared to Rs 122.16 crore for the same quarter in the previous year. Total income of the company increased by 39.68% at Rs 2,485.70 crore for Q1FY24 as compared Rs 1,779.53 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 9.48% rise in its net profit at Rs 569.71 crore for the first quarter ended June 30, 2023 as compared to Rs 520.38 crore for the same quarter in the previous year. Total income of the company increased by 11% at Rs 6,966.85 crore for Q1FY24 as compared Rs 6,276.54 crore for the corresponding quarter previous year.

Aurobindo Pharma Share Price

1209.90 16.85 (1.41%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.35
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 913.85
Lupin 2118.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×